Reducing mechanical activation-induced amorphisation of salbutamol sulphate by co-processing with selected carboxylic acids

被引:19
作者
Curtin, Vincent [1 ]
Amharar, Youness [1 ]
Gallagher, Kieran H. [1 ]
Corcoran, Sarah [1 ]
Tajber, Lidia [1 ]
Corrigan, Owen I. [1 ]
Healy, Anne Marie [1 ]
机构
[1] Univ Dublin Trinity Coll, Sch Pharm & Pharmaceut Sci, Panoz Inst, Dublin 2, Ireland
基金
爱尔兰科学基金会;
关键词
Mechanical activation; Amorphous; Glass transition temperature; Salbutamol sulphate; Crystalline; GLASSY PHARMACEUTICALS; AMORPHOUS CONTENT; SOLUBLE DRUGS; STATE; CRYSTALLINE; SOLUBILITY; QUANTIFICATION; TRANSFORMATION; GRISEOFULVIN; TEMPERATURE;
D O I
10.1016/j.ijpharm.2013.08.025
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The unintentional generation of amorphous character in crystalline active pharmaceutical ingredients (APIs) is an adverse consequence of mechanical activation during dosage form manufacture. In this study, we assess and compare the ability of low glass transition temperature (T-g) dicarboxylic acids to mitigate amorphisation of a model API, salbutamol sulphate (SS), on both co-milling and co-mixing. SS processed alone, as well as co-milled and co-mixed composites of the API with glutaric acid (GA), adipic acid (AA) and pimelic acid (PA) were characterised by powder X-ray diffraction (pXRD), differential scanning calorimetry (DSC) and dynamic vapour sorption (DVS). Milling and dry mixing of SS both resulted in pXRD amorphous materials. No amorphous content of SS was detected by DVS on co-milling with 50% (w/w) GA, while amorphisation was more than halved, relative to the API milled alone, on co-milling with 50% (w/w) AA and PA, respectively. Co-mixing with each excipient also resulted in a decrease in API amorphicity, although the extent of reduction was considerably less compared to the co-milling experiments. The solubility (Sol(excipient)) of each excipient in amorphous SS was determined by thermal methods. No further reduction in API amorphisation was achieved on co-mixing with 50% (w/w) excipient, compared to concentrations corresponding to the solubility of each excipient in the amorphous API (Sol(GA) = 36%, Sol(AA) = 21%, Sol(PA) = 22%). PXRD confirmed gradual dissolution over time of GA in amorphous SS on co-mixing. In contrast to co-mixing, co-milling SS at excipient weight fractions above their respective solubilities in the amorphous drug resulted in further reductions in API amorphisation. This is thought to be due to the generation of a molecular dispersion of amorphous API, supersaturated with excipient, thereby leading to a more pronounced composite T-g lowering effect. The results indicate that co-processing with low T-g excipients is an effective strategy at minimising amorphisation of an API on mechanical activation. (C) 2013 Published by Elsevier B.V.
引用
收藏
页码:508 / 516
页数:9
相关论文
共 30 条
[21]   Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API [J].
McNamara, Daniel P. ;
Childs, Scott L. ;
Giordano, Jennifer ;
Iarriccio, Anthony ;
Cassidy, James ;
Shet, Manjunath S. ;
Mannion, Richard ;
O'Donnell, Ed ;
Park, Aeri .
PHARMACEUTICAL RESEARCH, 2006, 23 (08) :1888-1897
[22]   Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes [J].
Morris, KR ;
Griesser, UJ ;
Eckhardt, CJ ;
Stowell, JG .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 48 (01) :91-114
[23]   The effect of dry mixing on the apparent solubility of hydrophobic, sparingly soluble drugs [J].
Mosharraf, M ;
Nyström, C .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 9 (02) :145-156
[24]   Solid-state characterization of two polymorphic forms of R-albuterol sulfate [J].
Palacio, M. A. ;
Cuffini, S. ;
Badini, R. ;
Karlsson, A. ;
Palacios, S. M. .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 43 (04) :1531-1534
[25]   Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling [J].
Patterson, James E. ;
James, Michael B. ;
Forster, Angus H. ;
Lancaster, Robert W. ;
Butler, James M. ;
Rades, Thomas .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 336 (01) :22-34
[26]   Drug-Polymer Solubility and Miscibility: Stability Consideration and Practical Challenges in Amorphous Solid Dispersion Development [J].
Qian, Feng ;
Huang, Jun ;
Hussain, Munir A. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (07) :2941-2947
[27]   Solid State Amorphization of Pharmaceuticals [J].
Willart, J. F. ;
Descamps, M. .
MOLECULAR PHARMACEUTICS, 2008, 5 (06) :905-920
[28]   Solid-state vitrification of crystalline griseofulvin by mechanical milling [J].
Willart, Jean-Francois ;
Carpentier, Laurent ;
Dannede, Florence ;
Descamps, Marc .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (04) :1570-1577
[29]   Direct crystal to glass transformation of trehalose induced by ball milling [J].
Willart, JF ;
De Gusseme, A ;
Hemon, S ;
Odou, G ;
Danede, F ;
Descamps, M .
SOLID STATE COMMUNICATIONS, 2001, 119 (8-9) :501-505
[30]   Amorphous pharmaceutical solids: preparation, characterization and stabilization [J].
Yu, L .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 48 (01) :27-42